Carlos Fernandez Del Castillo, MD

Articles by Carlos Fernandez Del Castillo, MD

Current Perspectives on Locally Advanced Pancreatic Cancer

ByBrian G. Czito, MD,Christopher G. Willett, MD,Jeffrey W. Clark, MD,Carlos Fernandez Del Castillo, MD

November 1st 2000

This year, approximately 40% of the 28,300 patients diagnosed with pancreatic carcinoma in the United States will present with locally advanced disease. Radiotherapeutic approaches are often employed, as these patients

Latest Updated Articles

Current Perspectives on Locally Advanced Pancreatic Cancer
November 1st 2000

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)